presbyopia,vision,OcularSurgeryNews,eyedrop

Mashup Score: 0

Brimochol PF achieves endpoints in second phase 3 presbyopia trial - 6 hour(s) ago

Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 pivotal trial, according to a press release from Tenpoint Therapeutics.

Source: www.healio.com

Categories: General Medicine News, Ophthalmology

Tweet Tweets with this article
- Healio_OSN
  
  Patients with #presbyopia experienced improvements in near #vision after treatment with Brimochol PF. Read the full article🔗 #OcularSurgeryNews #eyedrop @Tenpoint_Tx https://t.co/c2WJm9wAlz https://t.co/GNDeUCJnUv